Fig. 1From: Trying to identify who may benefit most from future vitamin D intervention trials: a post hoc analysis from the VITDAL-ICU study excluding the early deathsDifference among survivors and non-survivors at 28 days, in the treatment group, on day 3 values of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin DBack to article page